Alesi Surgical Limited, the leading innovator of minimally invasive surgery technologies has successfully secured FDA (Food and Drug Administration) approval for its Ultravision™ system. The Ultravision™ system is a world first that clears the vapour and particulate matter generated by modern surgical cutting instruments during abdominal keyhole (laparoscopic) surgery through the use of electrostatic technology. […]
Alesi Surgical, a leading innovator of advanced minimally invasive surgery technologies, and Adachi Co., Ltd. today announce regulatory approval of the Ultravision™ visual field clearing system by the Japanese Ministry of Health, Labour and Welfare and an exclusive agreement in Japan. Adachi Co., Ltd. was founded as a family-owned medical and scientific products distributor in […]
A spin-out medical device company from a leading surgical training institute at Cardiff University is one of 12 UK companies representing the country’s health and life science industry in Texas next week (15th to 21st October 2016).Alesi Surgical, developer of the revolutionary Ultravision system, which manages surgical smoke during laparoscopic keyhole surgery, will form part […]
Alesi Surgical Limited, the advanced minimally invasive surgery medical device manufacturer, has announced its entry into the lucrative trocar market estimated to be worth $800 million per year, globally.
Alesi Surgical the medical device company developing novel technologies to enhance outcomes in minimally invasive surgery, announced the appointment of Marcus Dyer as International Sales and Marketing Manager.
The company will be demonstrating its lead product, Ultravision™ which eliminates surgical smoke during laparoscopic (keyhole) surgery and provides a continuously clear visual field for the operating surgeon. Ultravision uses electrostatic precipitation, a proven method of clearing vapour and particulate matter, which otherwise would be released into the operating room. Dr Dominic Griffiths, Managing Director […]
Alesi Surgical (formerly Asalus Medical Instruments Limited) announced today that it has secured additional funding of £2.1 million to drive the further commercialisation of its lead product, UltravisionTM, which was developed from concept to CE-marked device with backing from IP Group and Finance Wales. The funding comes at an important inflection point for the Company. […]